Exact Sciences CorporationEXASNASDAQ
Loading
R&D Expense Growth AcceleratingAccelerating
Percentile Rank97
3Y CAGR+155.1%
5Y CAGR-45.5%
Year-over-Year Change
Year-over-year research & development expense growth
3Y CAGR
+155.1%/yr
vs -35.3%/yr prior
5Y CAGR
-45.5%/yr
Recent acceleration
Acceleration
+190.4pp
Accelerating
Percentile
P97
Near historical high
vs 5Y Ago
0x
Contraction
Streak
2 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 63.27% |
| Q3 2025 | 7.70% |
| Q2 2025 | 3.41% |
| Q1 2025 | 5.71% |
| Q4 2024 | -1.84% |
| Q3 2024 | -16.23% |
| Q2 2024 | 9.27% |
| Q1 2024 | -3.53% |
| Q4 2023 | 3.12% |
| Q3 2023 | 7.06% |
| Q2 2023 | 9.09% |
| Q1 2023 | 1.21% |
| Q4 2022 | 3.81% |
| Q3 2022 | -14.39% |
| Q2 2022 | 3.75% |
| Q1 2022 | 15.55% |
| Q4 2021 | 17.43% |
| Q3 2021 | -29.07% |
| Q2 2021 | -8.07% |
| Q1 2021 | -74.11% |
| Q4 2020 | 1318.45% |
| Q3 2020 | -3.68% |
| Q2 2020 | -24.91% |
| Q1 2020 | 2.30% |
| Q4 2019 | 21.71% |
| Q3 2019 | 15.70% |
| Q2 2019 | -5.66% |
| Q1 2019 | 52.95% |
| Q4 2018 | 18.72% |
| Q3 2018 | 19.84% |
| Q2 2018 | -1.49% |
| Q1 2018 | 17.83% |
| Q4 2017 | 8.10% |
| Q3 2017 | 20.42% |
| Q2 2017 | 21.68% |
| Q1 2017 | 12.99% |
| Q4 2016 | -7.12% |
| Q3 2016 | -11.75% |
| Q2 2016 | -14.68% |
| Q1 2016 | 8.13% |